The five ethical questions we won't build without answering
It's tempting to treat ethics as something you bolt on once the technology works. We think that's exactly backwards. For a project like Amnia, the ethical questions are the design constraints — and if we can't answer them honestly, we have no business building the hardware at all.
Here are the five we return to most, and where our thinking currently stands. We're publishing them not because we've solved them, but because we want to be held to them.
1. Whose interests come first?
The developing child cannot consent, advocate, or choose. That makes their wellbeing the non-negotiable center of every decision — ahead of speed, ahead of cost, ahead of any adult's wishes. In practice this means an independent ethics board with real veto power over milestones, and a rule we've written down: if a design trades the child's safety for anyone's convenience, it doesn't ship.
2. What counts as "ready" for a first human use?
The honest answer is: a far higher bar than "it worked in the lab." A first clinical use would only ever be as a bridge to viability for an infant who is already fighting for life in intensive care — never an elective first step. Even that is gated behind years of preclinical evidence and formal regulatory review. We laid out those gates in detail in our regulatory roadmap, precisely so no one — including us — can quietly move the line.
3. Who gets access — and who doesn't?
A technology that only the wealthy can reach would deepen the very inequities in maternal and neonatal health it should help close. We don't have a pricing model to announce, and we're wary of anyone who claims to this early. But we can state the intent plainly: equity of access is a design goal, not a marketing afterthought. If exogenesis becomes a luxury good, we will have failed at something more important than the engineering.
4. What does it do to identity and belonging?
Gestation is not just biological plumbing — it's the beginning of a story a person tells about where they came from. A child born through an artificial womb deserves that story to be whole and honest. That shapes small things (how a parent's recorded voice and presence are woven in) and large ones (how openly we talk about the technology, so it's never a secret to be ashamed of).
5. Where does caution end and paralysis begin?
There's an ethical cost to not building this, too. Every year, families lose infants to extreme prematurity that a mature version of this technology might one day help. Refusing to try is also a choice with a body count. Our answer isn't to rush — it's to move deliberately, publish honestly, and let independent scrutiny, not our own enthusiasm, set the pace.
None of these have tidy endings. That's the point: they're commitments we re-earn with every decision, in public. If you want to follow how we navigate them, the waitlist gets one honest update a month.
